Book an Appointment

Yes. A fetal echocardiogram is completely safe for both the baby and the mother. It uses standard ultrasound technology with no radiation involved and no known risk at any stage of pregnancy. The same technology that’s been used in routine pregnancy scans for decades. Just applied more carefully and for longer to look specifically at the heart.

“A fetal echo uses the exact same ultrasound waves as a routine pregnancy scan. There is no radiation. No risk to the baby. Just a longer, more detailed look at a heart that deserves that attention,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

Most parents asking this question aren’t really asking about physics. They’re asking whether something is going to hurt their baby. And the honest answer is no. Nothing about this scan puts your baby at risk in any way.

• No radiation whatsoever: Unlike X-rays or CT scans a fetal echocardiogram uses only sound waves to build its images and sound waves don’t damage tissue, don’t affect developing cells and don’t accumulate in the body in a way that causes any problem at all.
• Same technology as a routine scan: The transducer pressed against the abdomen is identical to what gets used in every standard pregnancy ultrasound and the only difference is the operator’s focus, the duration and how carefully those heart structures get examined frame by frame.
• Can be repeated without concern: If the baby’s position makes imaging difficult the first time or if a follow up scan is needed to monitor a finding there’s no limit on how many times a fetal echo can be safely done and no cumulative risk that builds up with repeat scans.
• No needles, no sedation, nothing invasive: The entire scan happens externally through the mother’s abdomen and in some cases a transvaginal probe is used for earlier scans but nothing enters the uterus, nothing touches the baby and nothing about the process is invasive at any point.

Understanding what the scan actually involves is what makes fetal echocardiography feel like something you’re walking into with your eyes open rather than something that was just added to your appointment list without any real explanation.

Because the safety question is usually followed by a practical one. What actually happens in that room. How long is it. Will something feel wrong. And what do you do if the scan finds something you weren’t expecting to hear about that day.

• The scan takes 30 to 60 minutes: Longer than a routine anomaly scan because the cardiologist is examining every chamber, every valve, every vessel and watching blood flow in real time rather than taking a quick look and moving on to the next item on the checklist.
• You’ll feel nothing unusual: Warm gel on the abdomen, a transducer pressed gently against the skin and a lot of quiet concentration from the person doing the scan. Some babies cooperate immediately. Others take their time settling into a position that shows what needs to be seen.
• Results are usually discussed the same day: A paediatric cardiologist performing the scan can give you a clear picture of what was found or what wasn’t found before you leave the room and that conversation is often the part families feel most unprepared for regardless of what the answer turns out to be.
• A normal result is genuinely reassuring: Not a perfect guarantee because some very small defects only become visible after birth but a normal fetal echo from an experienced specialist means the vast majority of significant structural problems have been looked for and not found.

Parents in a high risk category wanting to understand what happens if something does get found during the scan should read this piece on importance of fetal diagnosis of critical congenital heart disease which explains honestly what an early prenatal finding actually changes about the care plan and the options available to families from that point.

A fetal echo being safe doesn’t mean every fetal echo is equally useful. The safety is in the technology. The value is entirely in the person reading it. Dr. Prashant Bobhate trained at Escorts Heart Institute in New Delhi then went specifically to the University of Alberta in Canada for advanced paediatric cardiac fellowship training. Over 12 years reading these scans and then following those same babies through every stage of what came after. His team performed India’s very first successful Transcatheter Potts Shunt and actively manages over 400 children on advanced therapy right now. He doesn’t just tell you the scan was normal or abnormal. He tells you what it actually means for your specific baby and what needs to happen next because of it.

• Fetal Echocardiography Overview, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/ency/article/003813.htm
• Congenital Heart Defects, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects

Congenital heart disease can be hereditary but it isn’t always. Some types carry a clear genetic link and run through families for generations. Others show up with zero family history anywhere. Most cases are actually a mix of genetic vulnerability and something that happened in those first few weeks of pregnancy before most people even knew they were pregnant.

“Genetics plays a role in congenital heart disease but it’s rarely the whole story. Understanding your specific risk is what allows families to plan rather than just worry,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

This question doesn’t stay academic for long. The moment a cardiac diagnosis lands in your family it becomes the most personal thing in the room.

• Single gene mutations: Noonan syndrome, Marfan syndrome, DiGeorge syndrome. Each one carries a specific mutation that raises structural heart defect risk significantly and each one can pass from parent to child in a pattern a genetic counsellor can actually trace through your specific family rather than just quoting you a percentage and sending you home.
• Chromosomal abnormalities: Down syndrome, Turner syndrome, trisomy 18. All of them carry substantially elevated rates of congenital heart findings and in these cases the cardiac piece isn’t standalone at all it’s part of a much broader picture that genuinely needs to be understood as a whole thing not in fragments.
• Familial recurrence risk: If one parent has congenital heart disease their child’s risk sits around 3 to 5 percent. Compare that to under 1 percent in the general population. And if a previous child was already affected that number shifts again depending entirely on which specific defect we’re actually talking about.
• Multifactorial inheritance: Here’s the honest part most families don’t hear clearly enough. Most congenital heart cases don’t follow a clean genetic pattern. They’re a combination of multiple small genetic variants mixing with environmental exposures during those first eight weeks when the heart is literally being built from nothing.

That specific picture in your family is what makes the right congenital heart disease planning conversation actually useful rather than just vaguely reassuring in a way that doesn’t change anything practically for you.

Because plenty of families with no cardiac history anywhere end up sitting in a paediatric cardiology clinic. 

• Maternal diabetes in the first trimester: Poorly controlled blood sugar during those first twelve weeks more than triples the baseline risk of a structural heart defect forming and it happens during the exact window when the cardiac chambers and valves are being built completely from scratch for the very first time.
• Certain medications taken early: Lithium, some antiepileptics, heavy alcohol during the first trimester. All of them carry documented associations with specific cardiac defect types and none of it has anything to do with what does or doesn’t run in your family.
• Rubella and certain infections: This one still surprises people. A rubella infection in the first trimester remains one of the oldest known causes of congenital heart disease and it’s still relevant today wherever vaccination coverage isn’t as solid as the numbers on paper suggest it should be.
• Maternal autoimmune conditions like lupus: Antibodies can cross the placenta and quietly interfere with the baby’s cardiac conduction system producing problems that look genetic on the surface but trace back to something completely different when you actually follow the thread properly.

Parents who received a congenital heart finding before birth and want to understand what early detection actually changes should read this piece on importance of fetal diagnosis of critical congenital heart disease which goes through honestly what a prenatal diagnosis means for the care plan and the options available from that point forward.

Understanding whether what’s in your family carries a hereditary pattern isn’t something you want answered by someone who encounters this occasionally and figures it out as they go. Dr. Prashant Bobhate spent over 12 years specifically inside congenital cardiac disease in children. Fetal diagnosis. Intervention. Long term follow up. All of it. Trained at Escorts Heart Institute in New Delhi then went deliberately to the University of Alberta in Canada for advanced paediatric cardiac fellowship training. His team performed India’s very first successful Transcatheter Potts Shunt and actively manages over 400 children on advanced therapy right now. He doesn’t hand families a generic recurrence number from a textbook. He looks at your specific defect, your specific family history and builds the actual picture entirely from there.

• Congenital Heart Defects, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/congenitalheartdefects.html
• Congenital Heart Disease Causes, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects/causes

A fetal echocardiogram can detect structural heart defects, abnormal blood flow patterns, valve problems, rhythm disturbances and major vessel abnormalities in an unborn baby. It gives a far more detailed picture of your baby’s heart than a routine anomaly scan ever will. And that difference in detail is exactly why it exists as a separate scan entirely.

“A fetal echo doesn’t just look at the heart. It reads how the heart is working, how blood is moving through it and whether anything is building that needs to be caught right now rather than after birth,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

Most parents walking into this scan don’t know how much it can actually see. A routine 20-week anomaly scan checks the heart briefly. 

• Ventricular septal defects: Holes between the lower chambers of the heart that let blood cross where it shouldn’t and while small ones sometimes close on their own larger ones need to be on the radar before birth so nothing about the delivery or immediate care comes as a surprise.
• Transposition of the great arteries: The two main arteries leaving the heart have completely swapped positions and this is genuinely one of those findings where catching it before birth rather than in the first hours of life changes the entire outcome for that baby.
• Hypoplastic left heart syndrome: The entire left side of the heart is severely underdeveloped and without a fetal diagnosis this one walks into the delivery room completely unannounced and the difference in survival between a prepared team and an unprepared one is stark.
• Pulmonary and aortic valve abnormalities: Valves that are too narrow, leaking or structurally malformed in ways that affect how blood moves in and out of the heart and ones that a routine scan simply doesn’t have the resolution or the time to assess properly.

These are exactly the kinds of findings that make fetal echocardiography one of the most important scans a high risk pregnancy can have rather than an optional extra someone added to the list.

Because it isn’t just about structure. A heart can be built correctly and still not work the way it should. And some of the most important things a fetal echo finds aren’t holes or missing pieces but problems with how the heart is actually beating and moving blood around.

• Fetal arrhythmias: Heartbeats that are too fast, too slow or completely irregular in a pattern that no routine midwife check would ever catch properly and some of these need treatment that starts before birth rather than waiting until after delivery.
• Abnormal blood flow across valves: Doppler imaging inside the fetal echo shows exactly how fast blood is moving and in which direction and flow that looks wrong is often the first sign of a valve problem that would otherwise stay invisible until symptoms appeared months later.
• Fetal heart block: The electrical signals telling the heart to beat aren’t getting through properly and this can be connected to maternal autoimmune conditions the mother didn’t even know were affecting her baby’s cardiac conduction system in the background.
• Tumours and structural masses: Cardiac rhabdomyomas sometimes spotted incidentally during a fetal echo and while most are benign they carry associations with other conditions that need to be on the clinical radar before birth rather than discovered afterwards entirely by accident.

Parents wanting to understand what happens when one of these findings does come up before birth should read this piece on importance of fetal diagnosis of critical congenital heart disease which goes through honestly what early detection actually changes about the care plan and the options available to families from that point forward.

Finding something on a fetal echo is only half of it. Understanding what it means and what needs to happen next is where the real experience shows. Dr. Prashant Bobhate didn’t come to this area by accident. He trained at Escorts Heart Institute in New Delhi then went specifically to the University of Alberta in Canada for advanced paediatric cardiac fellowship training. Over 12 years reading these scans, following those babies through birth, through intervention and through recovery. His team performed India’s very first successful Transcatheter Potts Shunt and actively manages over 400 children on advanced therapy right now. He doesn’t just report what he sees. He tells you what it means for your specific baby.

• Fetal Echocardiography Overview, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/ency/article/003813.htm
• Congenital Heart Defects in Children, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects

A fetal echocardiogram is generally recommended between 18 and 24 weeks of pregnancy. That’s when your baby’s heart is developed enough to show everything that needs to be seen clearly. Done too early and the picture is incomplete. Done too late and the imaging gets harder. The window is real and the timing genuinely matters.

“The timing of a fetal echocardiogram isn’t a suggestion. It’s the difference between getting a clear picture of your baby’s heart and getting an incomplete one that raises more questions than it answers,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India

Most parents assume any week is fine as long as the scan happens before birth. It isn’t. What a specialist can reliably see changes dramatically depending on exactly when you walk through that door.

• 18 to 24 weeks is the gold standard: The heart is developed enough at this stage to show all four chambers clearly, the valves, the major vessels and the way blood is actually flowing through all of it in real time without guessing.
• Earlier than 18 weeks misses things: A scan done at 14 or 15 weeks might catch the most obvious structural problems but smaller defects and valve abnormalities genuinely cannot be seen clearly enough to assess properly at that gestational age.
• Later than 24 weeks has its own problems: The baby is larger, harder to position and the acoustic window through the mother’s abdomen gets more difficult which means image quality drops and what can be confirmed reliably starts shrinking.
• 20 to 22 weeks hits the sweet spot: Most specialists will tell you this is the ideal range because the heart is fully formed enough to examine comprehensively while the baby is still small enough to get the imaging angles that actually show what needs to be seen.

Understanding exactly when your fetal echocardiography needs to happen is what makes the difference between a scan that genuinely answers your questions and one that leaves everyone uncertain about what was and wasn’t seen.

Not every pregnancy gets referred for this and a lot of parents who should be getting one never do because nobody flagged the risk factor sitting right there in their medical history.

• Family history of heart defects: If you or your partner or a previous child had a congenital heart problem that risk is elevated enough that a fetal echo between 20 and 22 weeks isn’t optional it’s genuinely necessary.
• Maternal diabetes or lupus: Both conditions affect fetal cardiac development in ways that don’t always show on a routine anomaly scan and both warrant a dedicated cardiac look at the right gestational window.
• Abnormal findings on routine scan: An anomaly scan that flagged anything suspicious about the heart, the vessels or the rhythm is a direct referral indication and waiting to see if the next scan looks better is not the right response.
• IVF pregnancies and multiple gestations: Both carry elevated rates of congenital heart findings compared to spontaneous singleton pregnancies and both deserve a fetal echo rather than relying on routine screening alone to catch what’s there.

Parents already in a high risk category wanting to understand what happens when a problem does get found before birth should read this piece on importance of fetal diagnosis of critical congenital heart disease which explains honestly what early detection actually changes about the options available to families.

A fetal echo is only as useful as the person interpreting what’s on that screen and that’s not a small distinction when it’s your baby’s heart being assessed before birth. Dr. Prashant Bobhate trained at Escorts Heart Institute in New Delhi then went specifically to the University of Alberta in Canada for advanced paediatric cardiac fellowship training. Over 12 years working with babies from before birth through every stage and complexity of congenital heart disease.

• Fetal Echocardiography Overview, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/ency/article/003813.htm
• Congenital Heart Defects, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/congenital-heart-defects

Not one drug. Never just one. Pulmonary hypertension medication works across multiple pathways simultaneously because the disease attacks the lung arteries from more than one direction at once and treating only one pathway while the others continue quietly doing damage is how children end up worse despite being on treatment. The right combination, at the right doses, started early enough, is what actually changes the trajectory.

“Families often arrive expecting a single tablet that fixes the pressure. The reality is we’re managing three separate biological pathways at the same time and getting that combination right for each individual child is where the real clinical work actually lives,” says Dr. Prashant Bobhate, Pediatric Cardiologist in Mumbai, India.

The drugs used in PH don’t just lower pressure the way blood pressure tablets lower systemic hypertension. They work on specific molecular pathways inside the pulmonary vessel walls and each class targets a different part of the problem. 

• Phosphodiesterase-5 inhibitors: Sildenafil is the one most paediatric PH specialists reach for first. It works by keeping the vessels relaxed and open through a nitric oxide pathway and it has a reasonable evidence base in children specifically, not just adults, which matters enormously when you’re treating a six year old.
• Endothelin receptor antagonists: Bosentan and ambrisentan block endothelin, a protein the diseased pulmonary vessels produce in excess that drives vasoconstriction and abnormal wall growth. These are oral drugs which makes them manageable for long term paediatric use but they need regular liver function monitoring throughout treatment.
• Prostacyclin pathway agents: The most potent class. Treprostinil, iloprost, epoprostenol. Some inhaled, some subcutaneous, some intravenous. Used when the disease is more advanced or when simpler combinations aren’t holding the pressures adequately. Not easy drugs to manage at home but genuinely life-extending when they’re needed.
• Soluble guanylate cyclase stimulators: Riociguat works on a different part of the nitric oxide pathway to the PDE5 inhibitors and offers an alternative route particularly useful in specific PH subtypes where the standard combination isn’t delivering the response the child’s pressures need.

Understanding where your child sits on the treatment ladder right now and what needs to change is exactly what a specialist pulmonary hypertension medical management review puts on the table before any prescription decision gets made.

Yes. And this is moving faster than most families realise. The last few years have brought drugs that don’t just manage symptoms or slow progression but actually target the structural changes happening inside the pulmonary vessel walls in a way no previous medication could. That’s a genuinely different category of treatment and it’s already reaching patients in India.

• Sotatercept: This is the one generating the most real world clinical excitement right now. It works on a completely different biological mechanism to everything that came before it, targeting the activin signalling pathway that drives abnormal vessel wall remodelling. Early clinical experience including from Indian centres shows meaningful pressure reductions in patients who weren’t responding adequately to conventional combination therapy.
• Combination therapy from diagnosis: The old approach was to start one drug and add more only when things worsened. Current evidence strongly supports initiating combination therapy upfront in newly diagnosed patients rather than waiting for deterioration to force escalation. Starting right matters as much as starting early.
• Right heart monitoring alongside drugs: Medication decisions in PH can’t happen in isolation from what the right ventricle is doing in response. A drug combination that looks good on paper but isn’t translating into right heart recovery on echo is a combination that needs reassessing regardless of what the guidelines suggest for the average patient.
• Personalised escalation plans: No two children with PH respond identically to the same drug combination and building an escalation plan at diagnosis rather than reacting to crises as they arrive is what separates centres that genuinely specialise in this from those that manage it generically.

Families wanting to understand what sotatercept has meant for real patients in India should read this piece on sotatercept changing how PAH is managed because the gap between what was possible two years ago and what’s possible now for PH patients is significant and still widening.

You want someone who has seen every version of this. Not just the textbook ones but the child whose SVT only triggers during school exams and the teenager whose WPW sat silently for three years before one football match changed the picture entirely. Dr. Prashant Bobhate has spent over 12 years working across the full spectrum of paediatric cardiac conditions including complex arrhythmia presentations at every age from newborn through adolescence. Trained at Escorts Heart Institute New Delhi and completed advanced fellowship at the University of Alberta Canada with focused exposure to paediatric electrophysiology alongside structural disease.

• Pulmonary Hypertension, MedlinePlus, U.S. National Library of Medicine — https://medlineplus.gov/pulmonaryhypertension.html
• Pulmonary Arterial Hypertension, National Heart Lung and Blood Institute — https://www.nhlbi.nih.gov/health/pulmonary-hypertension